模拟124I-MIBG心脏PET/CT三代扫描仪图像质量与病灶可检测性体模研究
该体模研究比较模拟124I-MIBG心脏显像在三代PET/CT(模拟标准轴视野、数字标准轴视野、长轴视野)中的图像质量和病灶可检测性。LAFOV整体表现最佳,透壁缺损的SNR和CNR在10分钟时显著高于模拟SAFOV,支持缩短采集时间并可能降低给药活度,但低对比非透壁缺损优势不显著。
要点
- LAFOV PET/CT在模拟124I-MIBG心脏显像中图像质量和病灶可检测性最优。
- LAFOV支持更短采集时间和可能更低的给药活度。
- 低对比非透壁缺损的检测优势有限,需专门临床验证。
核心结论
- LAFOV PET/CT为模拟124I-MIBG心脏显像提供更优图像质量和病灶可检测性,支持缩短采集并可能降低给药活度。
- 该优势对高对比透壁缺损最明显,对低对比非透壁缺损的获益较不稳健。
研究设计与样本
- 使用带心脏插件的拟人躯干体模模拟124I-MIBG生理性生物分布。
- 设病理模型(透壁缺损和非透壁缺损)及正常均匀心肌摄取模型。
- 在三代PET/CT系统(模拟SAFOV、数字SAFOV、LAFOV)上采集10分钟列表模式数据并重建为1、5、10分钟,共九组数据集。
- 两名有经验读片者以5点Likert量表定性评估病灶可检测性和整体图像质量,并定量分析SNR和CNR。
- 采用传播测量不确定度的探索性成对Wald型比较。
主要发现
- LAFOV在所有采集时间点病灶可检测性最高,数字SAFOV居中,模拟SAFOV最低。
- 图像质量同样以LAFOV更优,尤其在5和10分钟时。
- 病理体模中SNR在LAFOV从25.9升至75.1,数字SAFOV从18.7升至41.8,模拟SAFOV从15.5升至17.1。
- 10分钟时探索性未校正成对比较显示LAFOV的SNR名义上高于模拟SAFOV(75.1 vs 17.1,p=0.028)。
- 透壁缺损的CNR在LAFOV增加最多,10分钟时名义上高于模拟SAFOV(67.6 vs 14.5,p=0.044)。
关键数值与推荐
- 病灶可检测性和整体图像质量采用5点Likert量表评分。
- 定量指标包括SNR和CNR。
- 成对比较采用探索性Wald型检验,基于传播测量不确定度。
临床怎么用
- LAFOV PET/CT可用于缩短124I-MIBG心脏显像采集时间并可能降低给药活度。
- 对高对比透壁缺损检测优势明确,对低对比非透壁缺损需谨慎解读。
- 细微部分神经支配缺损的可靠检测仍需专门临床验证。
局限性
- 研究基于体模模拟,非临床患者数据。
- 统计比较为探索性且未校正多重比较。
- 低对比非透壁缺损的扫描仪间差异未达统计学显著性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cardiac sympathetic imaging with iodine-labeled metaiodobenzylguanidine (MIBG) is clinically relevant for assessing autonomic dysfunction and arrhythmic risk in heart failure. The development of positron-emitting 124I-MIBG and new-generation PET/CT systems, particularly long axial field-of-view (LAFOV) scanners, may improve image quality and regional defect assessment while enabling protocol optimization. This study compared simulated cardiac 124I-MIBG image quality and lesion detectability across three PET/CT generations, analog standard axial field-of-view (SAFOV), digital SAFOV, and LAFOV, and explored the potential for acquisition-time and activity reduction. METHODS: An anthropomorphic torso phantom with cardiac insert was prepared to simulate physiologic 124I-MIBG biodistribution. Two configurations were studied: a pathological model with a transmural defect (TD) and a non-transmural defect (NTD), and a normal model with homogeneous myocardial uptake. Acquisitions were performed on three PET/CT systems: analog SAFOV (Biograph mCT), digital SAFOV (Biograph Vision Edge 600), and LAFOV (Biograph Vision Quadra). List-mode data were acquired for 10 min and reconstructed to simulate 1-, 5-, and 10-min acquisitions, yielding nine datasets. Qualitative assessment included lesion detectability and overall image quality scored on 5-point Likert scales by two experienced readers. Quantitative analysis included signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR). Exploratory pairwise Wald-type comparisons were performed using propagated measurement uncertainty. RESULTS: LAFOV PET/CT showed the best qualitative and quantitative performance overall. Lesion detectability was highest on LAFOV at all acquisition times, with digital SAFOV intermediate and analog SAFOV lowest. Image quality likewise favored LAFOV, especially at 5 and 10 min. In the pathological phantom, SNR increased from 25.9 to 75.1 on LAFOV, from 18.7 to 41.8 on digital SAFOV, and from 15.5 to 17.1 on analog SAFOV. At 10 min, exploratory uncorrected pairwise comparisons showed nominally higher SNR on LAFOV than on analog SAFOV PET/CT (75.1 vs 17.1, p = 0.028). For the transmural defect, CNR also increased most on LAFOV, with a nominally higher value versus analog SAFOV at 10 min (67.6 vs 14.5, p = 0.044). By contrast, for the low-contrast non-transmural defect, CNR was numerically higher on LAFOV at longer acquisition times, but the absolute inter-scanner differences were smaller and did not reach statistical significance. CONCLUSION: LAFOV PET/CT provides superior image quality and lesion detectability for simulated cardiac 124I-MIBG imaging and supports shorter acquisitions and potentially lower administered activity. However, the advantage was most pronounced for high-contrast transmural defects, whereas the benefit for low-contrast non-transmural defects was less robust. Reliable detection of subtle partial innervation defects remains challenging and requires dedicated clinical validation.
引用
- Aghapour Zangeneh F, Zeimpekis K, Gnesin S, et al. Image quality and lesion detectability in simulated [124I]MIBG cardiac imaging across 3-generation PET/CT scanners using a phantom model: Implications for activity and acquisition time reduction in clinical practice. Eur J Nucl Med Mol Imaging. 2026. PMID: 42440083. doi:10.1007/s00259-026-08065-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。